Syros Pharmaceuticals, Inc. (SYRS)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

24

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Sep-24 5:00 PM View:	16-Sep-24 Option Exercise 0	Young Richard A Director		Syros Pharmaceuticals, Inc. - SYRS	33% 8.0K to 10.67K	0	0	--	--	Show Txns Hide Txns

18-Sep-24 5:00 PM View:	16-Sep-24 Option Exercise 0	Akkaraju Srinivas Director		Syros Pharmaceuticals, Inc. - SYRS	40% 6.67K to 9.33K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 5:00 PM View:	12-Sep-24 Purchase $76.01K	Haas Jason Chief Financial Officer		Syros Pharmaceuticals, Inc. - SYRS	407% 24.55K to 124.55K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 5:00 PM View:	30-Sep-24 Payment of Exercise ($6.51K)	Quirk Gerald E Chief Legal & Compliance Offic		Syros Pharmaceuticals, Inc. - SYRS	17% 39.76K to 46.66K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 5:00 PM View:	11-Sep-24 Purchase $85.42K	Chee Conley President & CEO Director		Syros Pharmaceuticals, Inc. - SYRS	444% 22.5K to 122.5K	0	0	--	--	Show Txns Hide Txns